Telecom tycoon’s phase 3 pancreatic cancer bet flames out, sending stock to the basement
Telecom tycoon’s phase 3 pancreatic cancer bet flames out, sending [...]
Sanofi hit by filing delays for key drugs, drops an early Sangamo thalassemia asset
Sanofi hit by filing delays for key drugs, drops an [...]
How targeting a genetic signature of cellular stress may boost cancer immunotherapy
How targeting a genetic signature of cellular stress may boost [...]
Frazier has raised an $830M public life science fund. Here’s how it plans to invest the cash
Frazier has raised an $830M public life science fund. Here’s [...]
Duke and UC scientists find a potential remedy for chronic pain from a ‘junkyard of cancer drugs’
Duke and UC scientists find a potential remedy for chronic [...]
GSK, after pushing past midphase fail, ends development of otilimab in COVID-19
GSK, after pushing past midphase fail, ends development of otilimab [...]
Inclusion of women in stroke trials hasn’t changed in 30 years: study
Inclusion of women in stroke trials hasn’t changed in 30 [...]
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors
Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, [...]
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Novartis dumps Rett gene therapy caught up in Zolgensma scandal [...]
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Intellia, LogicBio fuel hope for in vivo gene editing with [...]